{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T11:20:42Z","timestamp":1788866442175,"version":"build-2803163510"},"reference-count":29,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2014,2,1]],"date-time":"2014-02-01T00:00:00Z","timestamp":1391212800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Human Pathology"],"published-print":{"date-parts":[[2014,2]]},"DOI":"10.1016\/j.humpath.2013.09.007","type":"journal-article","created":{"date-parts":[[2013,12,14]],"date-time":"2013-12-14T18:00:16Z","timestamp":1387044016000},"page":"320-326","source":"Crossref","is-referenced-by-count":54,"title":["Cutaneous and mammary apocrine carcinomas have different immunoprofiles"],"prefix":"10.1016","volume":"45","author":[{"given":"Adriano","family":"Piris","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Peng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chakib","family":"Boussahmain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lydia R.","family":"Essary","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas M.","family":"Gudewicz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mai P.","family":"Hoang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.humpath.2013.09.007_bb0005","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1016\/j.molonc.2009.01.005","article-title":"Molecular characterization of apocrine carcinoma of the breast: validation of an apocrine protein signature in a well-defined cohort","volume":"3","author":"Celis","year":"2009","journal-title":"Mol Oncol"},{"key":"10.1016\/j.humpath.2013.09.007_bb0010","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1002\/1097-0142(196804)21:4<756::AID-CNCR2820210428>3.0.CO;2-Y","article-title":"Carcinoma of the breast. Histologic and clinical features of apocrine tumors","volume":"21","author":"Frable","year":"1968","journal-title":"Cancer"},{"key":"10.1016\/j.humpath.2013.09.007_bb0015","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.breast.2004.06.003","article-title":"\u2018Pure\u2019 invasive apocrine carcinoma of the breast: a new clinicopathological entity?","volume":"14","author":"Japaze","year":"2005","journal-title":"Breast"},{"key":"10.1016\/j.humpath.2013.09.007_bb0020","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.clbc.2012.11.004","article-title":"Immunohistochemically defined subtypes and outcome of apocrine breast cancer","volume":"13","author":"Dellapasqua","year":"2013","journal-title":"Clin Breast Cancer"},{"key":"10.1016\/j.humpath.2013.09.007_bb0025","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1016\/S0344-0338(97)80053-2","article-title":"Immunohistochemical analysis of apocrine breast lesions. Consistent over-expression of androgen receptor accompanied by the loss of estrogen and progresterone receptors in apocrine metaplasia and apocrine carcinoma in situ","volume":"193","author":"Gatalica","year":"1997","journal-title":"Pathol Res Pract"},{"key":"10.1016\/j.humpath.2013.09.007_bb0030","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1038\/modpathol.2009.159","article-title":"Androgen receptor in breast cancer: expression in estrogen receptor\u2013positive tumors and in estrogen receptor-negative tumors with apocrine differentiation","volume":"23","author":"Niemeier","year":"2010","journal-title":"Mod Pathol"},{"key":"10.1016\/j.humpath.2013.09.007_bb0035","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1002\/jso.22023","article-title":"Cutaneous apocrine adenocarcinoma: defining epidemiology, outcomes, and optimal therapy for a rare neoplasm","volume":"105","author":"Hollowell","year":"2012","journal-title":"J Surg Oncol"},{"key":"10.1016\/j.humpath.2013.09.007_bb0040","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1097\/PAS.0b013e3181590ba4","article-title":"Primary cutaneous apocrine carcinoma: a clinicopathologic analysis of 24 cases","volume":"32","author":"Robson","year":"2008","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.humpath.2013.09.007_bb0045","doi-asserted-by":"crossref","first-page":"e47290","DOI":"10.1371\/journal.pone.0047290","article-title":"Apocrine-eccrine carcinomas: molecular and immunohistochemical analyses","volume":"7","author":"Le","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.humpath.2013.09.007_bb0050","doi-asserted-by":"crossref","first-page":"975","DOI":"10.5858\/2009-0445-OAR2","article-title":"An immunohistochemical panel to differentiate metastatic breast carcinoma to skin from primary sweat gland carcinomas with a review of the literature","volume":"135","author":"Rollins-Raval","year":"2011","journal-title":"Arch Pathol Lab Med"},{"key":"10.1016\/j.humpath.2013.09.007_bb0055","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1038\/modpathol.2010.46","article-title":"The diagnostic utility of immunohistochemistry in distinguishing primary skin adnexal carcinomas from metastatic adenocarcinoma to skin: an immunohistochemical reappraisal using cytokeratin 15, nestin, p63, D2-40, and calretinin","volume":"23","author":"Mahalingam","year":"2010","journal-title":"Mod Pathol"},{"key":"10.1016\/j.humpath.2013.09.007_bb0060","first-page":"108","article-title":"Mammaglobin immunostaining in the differential diagnosis between cutaneous apocrine carcinoma and cutaneous metastasis from breast carcinoma","volume":"45","author":"Fernandez-Flores","year":"2009","journal-title":"Cesk Patol"},{"key":"10.1016\/j.humpath.2013.09.007_bb0065","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1200\/JCO.2006.09.2775","article-title":"American Society of Clinical Oncology\/College of American Pathologists guideline recommendations for human epidermal growth factor receptor 2 testing in breast cancer","volume":"25","author":"Wolff","year":"2007","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.humpath.2013.09.007_bb0070","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1038\/modpathol.2010.50","article-title":"EGFR and HER-2\/neu expression in invasive apocrine carcinoma of the breast","volume":"23","author":"Vranic","year":"2010","journal-title":"Mod Pathol"},{"key":"10.1016\/j.humpath.2013.09.007_bb0075","doi-asserted-by":"crossref","first-page":"1811","DOI":"10.1016\/j.humpath.2013.02.003","article-title":"Perilipin and adipophilin expression in sebaceous carcinomas and mimics","volume":"44","author":"Boussahmain","year":"2013","journal-title":"Hum Pathol"},{"key":"10.1016\/j.humpath.2013.09.007_bb0080","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1038\/modpathol.2010.1","article-title":"Adipophilin expression in sebaceous tumors and other cutaneous lesions with clear cell histology: an immunohistochemical study of 117 cases","volume":"23","author":"Ostler","year":"2010","journal-title":"Mod Pathol"},{"key":"10.1016\/j.humpath.2013.09.007_bb0085","doi-asserted-by":"crossref","first-page":"2547","DOI":"10.1194\/jlr.R700014-JLR200","article-title":"The perilipin family of structural lipid droplet proteins: stabilization of lipid droplets and control of lipolysis","volume":"48","author":"Brasaemle","year":"2007","journal-title":"J Lipid Res"},{"key":"10.1016\/j.humpath.2013.09.007_bb0090","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1097\/PAS.0b013e31821a7f3e","article-title":"Intracytoplasmic lipid accumulation in apocrine carcinoma of the breast evaluated with adipophilin immunoreactivity: a possible link between apocrine carcinoma and lipid-rich carcinoma","volume":"35","author":"Moritani","year":"2011","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.humpath.2013.09.007_bb0095","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/j.tem.2011.04.003","article-title":"Determinants of adipophilin's function in milk lipid formation of secretion","volume":"22","author":"Chong","year":"2011","journal-title":"Trends Endocrinol Metab"},{"key":"10.1016\/j.humpath.2013.09.007_bb0100","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1093\/ajcp\/109.1.75","article-title":"Homologous carcinomas of the breasts, skin and salivary glands: a histologic and immunohistochemical comparison of ductal mammary carcinoma, ductal sweat gland carcinoma and salivary duct carcinoma","volume":"109","author":"Wick","year":"1998","journal-title":"Am J Clin Pathol"},{"key":"10.1016\/j.humpath.2013.09.007_bb0105","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1111\/j.1600-0560.2006.00570.x","article-title":"Metastatic hidradenocarcinoma with demonstration of Her2\/neu gene amplification by fluorescence in situ hybridization: potential treatment implications","volume":"34","author":"Nash","year":"2007","journal-title":"J Cutan Pathol"},{"key":"10.1016\/j.humpath.2013.09.007_bb0110","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1038\/modpathol.2009.18","article-title":"Atypical and malignant hidradenomas: a histological and immunohistochemical study","volume":"22","author":"Nazarian","year":"2009","journal-title":"Mod Pathol"},{"key":"10.1016\/j.humpath.2013.09.007_bb0115","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1111\/j.1365-2559.2004.01843.x","article-title":"Preferential HER-2\/neu overexpression and\/or amplification in aggressive histological subtypes of invasive breast cancer","volume":"44","author":"Varga","year":"2004","journal-title":"Histopathology"},{"key":"10.1016\/j.humpath.2013.09.007_bb0120","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1111\/j.0303-6987.2004.00147.x","article-title":"The diagnostic utility of p63, CK5\/6, CK7, and CK20 in distinguishing primary cutaneous adnexal neoplasms from metastatic carcinomas","volume":"31","author":"Qureshi","year":"2004","journal-title":"J Cutan Pathol"},{"key":"10.1016\/j.humpath.2013.09.007_bb0125","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1097\/PAI.0b013e3181b94ff1","article-title":"Breast cancer molecular class ERBB2: preponderance of tumors with apocrine differentiation and expression of basal phenotype markers CK5, CK5\/6, and EGFR","volume":"18","author":"Bhargava","year":"2010","journal-title":"Appl Immunohistochem Mol Morphol"},{"key":"10.1016\/j.humpath.2013.09.007_bb0130","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1097\/00000372-200412000-00001","article-title":"Cytokeratin 5\/6 immunostaining in cutaneous adnexal neoplasms and metastatic adenocarcinoma","volume":"26","author":"Plumb","year":"2004","journal-title":"Am J Dermatopathol"},{"key":"10.1016\/j.humpath.2013.09.007_bb0135","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1038\/modpathol.3800263","article-title":"Expression of p63 in primary cutaneous adnexal neoplasms and adenocarcinoma metastatic to skin","volume":"18","author":"Ivan","year":"2005","journal-title":"Mod Pathol"},{"key":"10.1016\/j.humpath.2013.09.007_bb0140","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1038\/modpathol.3800731","article-title":"Breast-specific expression of MGB1\/mammaglobin: an examination of 480 tumors from various organs and clinicopathological analysis of MGB1-positive breast cancers","volume":"20","author":"Sasaki","year":"2007","journal-title":"Mod Pathol"},{"key":"10.1016\/j.humpath.2013.09.007_bb0145","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1309\/AJCP5UAFMSA9ZQBZ","article-title":"Immunohistochemical evaluation of GATA3 expression in tumors and normal tissues: a useful immunomarker for breast and urothelial carcinomas","volume":"138","author":"Liu","year":"2012","journal-title":"Am J Clin Pathol"}],"container-title":["Human Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0046817713003900?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0046817713003900?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,10,8]],"date-time":"2018-10-08T02:20:03Z","timestamp":1538965203000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0046817713003900"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,2]]},"references-count":29,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2014,2]]}},"alternative-id":["S0046817713003900"],"URL":"https:\/\/doi.org\/10.1016\/j.humpath.2013.09.007","relation":{},"ISSN":["0046-8177"],"issn-type":[{"value":"0046-8177","type":"print"}],"subject":[],"published":{"date-parts":[[2014,2]]}}}